Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Moxifloxacin versus cefuroxime prophylaxis in coronary artery bypass graft surgery with cardiopulmonary bypass
2006-000369-12Phase 4Completed
- Sponsor
- Institute of Anaesthesiology, German Heart Centre Munich
- Start
- Mar 2006
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in coronary arteriosclerosis comparing Moxifloxacin prophylaxis with Cefuroxime prophylaxis (2 arms). Primary endpoint: Difference in early inflammatory response between treatment groups. Started Mar 2006; status: completed.
02
Drugs
moxifloxacincefuroxime
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on 2006-000369-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000369-12.